Therapeutic strategies for optimal use of novel immunosuppressants

被引:12
作者
Keown, PA
机构
[1] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
关键词
D O I
10.1016/S0041-1345(99)00170-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1790 / 1792
页数:3
相关论文
共 26 条
[1]  
Amante AJ, 1996, TRANSPLANT P, V28, P2162
[2]   Rescue therapy with tacrolimus (FK 506) in renal transplant recipients - A Scandinavian multicenter analysis [J].
Felldin, M ;
Backman, L ;
Brattstrom, C ;
Bentdal, O ;
Nordal, K ;
Claesson, K ;
Persson, NH .
TRANSPLANT INTERNATIONAL, 1997, 10 (01) :13-18
[3]   Mycophenolate mofetil in renal allograft recipients - A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection [J].
Halloran, P ;
Mathew, T ;
Tomlanovich, S ;
Groth, C ;
Hooftman, L ;
Barker, C .
TRANSPLANTATION, 1997, 63 (01) :39-47
[4]  
Halloran PF, 1996, CLIN TRANSPLANT, V10, P118
[5]   Tacrolimus rescue therapy for renal allograft rejection - Five-year experience [J].
Jordan, ML ;
Naraghi, R ;
Shapiro, R ;
Smith, D ;
Vivas, CA ;
Scantlebury, VP ;
Gritsch, HA ;
McCauley, J ;
Randhawa, P ;
Demetris, AJ ;
McMichael, J ;
Fung, JJ ;
Starzl, TE .
TRANSPLANTATION, 1997, 63 (02) :223-228
[6]   Variable oral absorption of cyclosporine - A biopharmaceutical risk factor for chronic renal, allograft rejection [J].
Kahan, BD ;
Welsh, M ;
Schoenberg, L ;
Rutzky, LP ;
Katz, SM ;
Urbauer, DL ;
VanBuren, CT .
TRANSPLANTATION, 1996, 62 (05) :599-606
[7]  
KAHAN BD, P 17 WORLD C TRANSPL, P54
[8]   The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent [J].
Kaplan, B ;
Meier-Kriesche, HU ;
Napoli, KL ;
Kahan, BD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (01) :48-53
[9]   A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients [J].
Keown, P ;
Landsberg, D ;
Halloran, P ;
Shoker, A ;
Rush, D ;
Jeffery, J ;
Russell, D ;
Stiller, C ;
Muirhead, N ;
Cole, E ;
Paul, L ;
Zaltzman, J ;
Loertscher, R ;
Daloze, P ;
Dandavino, R ;
Boucher, A ;
Handa, P ;
Lawen, J ;
Belitsky, P ;
Parfrey, P .
TRANSPLANTATION, 1996, 62 (12) :1744-1752
[10]   INFLUENCE OF CYCLOSPORINE PHARMACOKINETICS, TROUGH CONCENTRATIONS, AND AUC MONITORING ON OUTCOME AFTER KIDNEY-TRANSPLANTATION [J].
LINDHOLM, A ;
KAHAN, BD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (02) :205-218